Internal Med Medical News about Andrographolide

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

5. Rapid correction of low vitamin D status in nursing home residents

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Andrographolide: A New Plant-Derived Antineoplastic Entity on Horizon
Evidence-based Complementary and Alternative Medicine , 09/23/09

Varma A et al. – In vitro studies demonstrate the capability of the compound of inducing cell–cycle arrest and apoptosis in a variety of cancer cells at different concentrations. Andrographolide also shows potent immunomodulatory and anti–angiogenic activities in tumorous tissues. Synthetic analogues of the compound have also been created and analyzed, which have also shown similar activities. Although it is too early to predict its future in cancer chemotherapy, the prologue strongly recommends further research on this molecule to assess its potential as a prospective anticancer agent.

<< Previous
Cognitive Impairment in Affective Psychoses: A Meta-analysis

Next >>
Influences of adult-onset diabetes on orofacial pain and related...